{"nct_id":"NCT04246047","title":"Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-09","start_date":"2020-05-07","start_date_type":"ACTUAL","primary_completion_date":"2023-10-02","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-19","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}